Jenny Hu

1.2k total citations
44 papers, 757 citations indexed

About

Jenny Hu is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Jenny Hu has authored 44 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Cardiology and Cardiovascular Medicine and 10 papers in Epidemiology. Recurrent topics in Jenny Hu's work include Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Nonmelanoma Skin Cancer Studies (9 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Jenny Hu is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Nonmelanoma Skin Cancer Studies (9 papers) and Atrial Fibrillation Management and Outcomes (5 papers). Jenny Hu collaborates with scholars based in United States, United Kingdom and Australia. Jenny Hu's co-authors include Melvin Chiu, Parrish Sadeghi, Sharona Yashar, Lauren Pinter‐Brown, J. L. Sullivan, Francesco Franchi, Fabiana Rollini, Dominick J. Angiolillo, Theodore A. Bass and Megha Kureti and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Jenny Hu

36 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jenny Hu United States	12	233	194	193	153	116	44	757
Jenny Öhman Sweden	17	262 1.1×	128 0.7×	317 1.6×	223 1.5×	36 0.3×	35	980
Jihong Zhao China	16	144 0.6×	186 1.0×	314 1.6×	431 2.8×	21 0.2×	79	1.1k
Taro Saito Japan	13	193 0.8×	72 0.4×	82 0.4×	156 1.0×	14 0.1×	35	531
Kemal Kösemehmetoğlu Türkiye	18	79 0.3×	399 2.1×	283 1.5×	181 1.2×	27 0.2×	96	1.3k
Ingo Ludolph Germany	18	39 0.2×	160 0.8×	152 0.8×	642 4.2×	100 0.9×	69	1.2k
Mirjana Radosevic Canada	7	42 0.2×	264 1.4×	203 1.1×	125 0.8×	11 0.1×	7	759
Yun Zhu United States	12	72 0.3×	60 0.3×	184 1.0×	131 0.9×	15 0.1×	22	604
Sybil B. Williams United States	22	156 0.7×	67 0.3×	207 1.1×	239 1.6×	9 0.1×	36	1.2k
B. Timothy Baxter United States	17	229 1.0×	76 0.4×	161 0.8×	459 3.0×	6 0.1×	33	1.2k
J. Schmitt Germany	5	527 2.3×	47 0.2×	203 1.1×	317 2.1×	12 0.1×	14	932

Countries citing papers authored by Jenny Hu

Since Specialization

Citations

This map shows the geographic impact of Jenny Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Hu more than expected).

Fields of papers citing papers by Jenny Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Hu. The network helps show where Jenny Hu may publish in the future.

Co-authorship network of co-authors of Jenny Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Hu. A scholar is included among the top collaborators of Jenny Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Hu. Jenny Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Jenny, et al.. (2025). A case of cutaneous angiosarcoma with intradermal metastases responding to PD-1 inhibition-based immunotherapy. JAAD Case Reports. 64. 67–70.

Dayyani, Farshid, et al.. (2025). Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective Study. Cancers. 17(2). 305–305.

Rodman, Jack, et al.. (2024). Effectiveness of a video-based intervention in improving skin cancer risk awareness and preventative behaviors among a diverse population of solid organ transplant recipients. JAAD International. 17. 172–174.

Koskimaki, Jacob E., Jenny Hu, Yiduo Zhang, et al.. (2022). Natural language processing-optimized case selection for real-world evidence studies.. Journal of Clinical Oncology. 40(16_suppl). 1556–1556. 2 indexed citations

Kroenke, Mark A., Jenny Hu, Lidong He, et al.. (2021). Immune Complex Formation Is Associated With Loss of Tolerance and an Antibody Response to Both Drug and Target. Frontiers in Immunology. 12. 782788–782788. 8 indexed citations

In, Gino K., Kevin G. King, Omar Ragab, et al.. (2020). PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California. Journal of Cancer Research and Clinical Oncology. 147(6). 1803–1811. 23 indexed citations

Adler, Brandon, Orr Shauly, Melanie M. Miller, et al.. (2019). Skin cancer and dermatoses in a majority-Hispanic population of solid organ transplant recipients. Journal of the American Academy of Dermatology. 83(2). 607–610. 3 indexed citations

Chow, Maggie, et al.. (2019). The Importance of Completely Removing Basal Cell Carcinoma at First Presentation. Dermatologic Surgery. 46(3). 416–418. 2 indexed citations

Franchi, Francesco, Fabiana Rollini, Yongwhi Park, et al.. (2019). Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine. JACC: Cardiovascular Interventions. 12(16). 1538–1549. 29 indexed citations

10.

Franchi, Francesco, Fabiana Rollini, Niti R. Aggarwal, et al.. (2016). Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. Circulation. 134(11). 780–792. 70 indexed citations

11.

Franchi, Francesco, Fabiana Rollini, Yongwhi Park, et al.. (2016). Abstract 19115: Effect of the Peripheral Opioid Receptor Antagonist Methylnaltrexone on the Pharmacokinetic and Pharmacodynamic Profiles of Ticagrelor in Patients Receiving Morphine: A Prospective Randomized Placebo-Controlled Trial. Circulation. 134. 2 indexed citations

12.

Franchi, Francesco, Gabriel Faz, Fabiana Rollini, et al.. (2016). Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor. JACC: Cardiovascular Interventions. 9(11). 1089–1098. 28 indexed citations

13.

Franchi, Francesco, Fabiana Rollini, Valeria E. Duarte, et al.. (2016). A PHARMACODYNAMIC COMPARISON OF PRASUGREL VERSUS TICAGRELOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CORONARY ARTERY DISEASE: THE OPTIMUS (OPTIMIZING ANTIPLATELET THERAPY IN DIABETES MELLITUS)-4 STUDY. Journal of the American College of Cardiology. 67(13). 22–22. 4 indexed citations

14.

Rollini, Fabiana, Francesco Franchi, Jenny Hu, et al.. (2016). Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention. Journal of the American College of Cardiology. 67(17). 1994–2004. 95 indexed citations

15.

Rollini, Fabiana, Francesco Franchi, Jung Rae Cho, et al.. (2016). IMPACT OF TIMING FROM BLOOD SAMPLING TO PHARMACODYNAMIC ASSESSMENT ON MEASURES OF PLATELET REACTIVITY IN PATIENTS TREATED WITH P2Y12 RECEPTOR INHIBITORS. Journal of the American College of Cardiology. 67(13). 214–214. 2 indexed citations

16.

Faz, Gabriel, Fabiana Rollini, Francesco Franchi, et al.. (2016). PHARMACODYNAMIC EFFECTS OF SWITCHING FROM PRASUGREL TO TICAGRELOR: RESULTS OF THE PROSPECTIVE, RANDOMIZED SWAP (SWITCHING ANTI PLATELET)-3 STUDY. Journal of the American College of Cardiology. 67(13). 215–215. 1 indexed citations

17.

Rollini, Fabiana, Francesco Franchi, Gabriel Faz, et al.. (2016). IN VITRO PHARMACODYNAMIC EFFECTS OF CANGRELOR ON PLATELET P2Y12 RECEPTOR MEDIATED SIGNALING IN TICAGRELOR TREATED PATIENTS. Journal of the American College of Cardiology. 67(13). 213–213. 1 indexed citations

18.

Hu, Jenny, Ho Jae Han, Francesca Civoli, et al.. (2015). Comparison of cell-based and non-cell-based assay platforms for the detection of clinically relevant anti-drug neutralizing antibodies for immunogenicity assessment of therapeutic proteins. Journal of Immunological Methods. 419. 1–8. 21 indexed citations

19.

Pereira, Clifford T., Erwin A. Kruger, Jenny Kim, et al.. (2013). Mohs Versus Surgical Excision in Nonmelanoma Skin Cancers. Annals of Plastic Surgery. 70(4). 432–434. 8 indexed citations

20.

Hu, Jenny, Parrish Sadeghi, Lauren Pinter‐Brown, Sharona Yashar, & Melvin Chiu. (2006). Cutaneous side effects of epidermal growth factor receptor inhibitors: Clinical presentation, pathogenesis, and management. Journal of the American Academy of Dermatology. 56(2). 317–326. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact